ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Uric Acid Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-30K7448
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Uric Acid Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Uric Acid Drug Market Research Report 2025

Code: QYRE-Auto-30K7448
Report
July 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Boehringer Ingelheim GmbH
Teijin Pharma Ltd
Regeneron Pharmaceuticals
GlaxoSmithKline PLC
Merck& Co. Inc
Novartis
Savient Pharmaceuticals
Ironwood Pharmaceuticals

Uric Acid Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Uric Acid Drug Market

Uric Acid Drug Market

The global market for Uric Acid Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Uric acid is the main metabolite of birds and reptiles. It is slightly soluble in water and easily forms crystals. The product in normal human urine is mainly urea, which contains a small amount of uric acid. Uric acid is the final product of purine metabolism. It is trioxypurine and its alcohol form is weakly acidic. People with high uric acid will have a serious problem in health.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Uric Acid Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uric Acid Drug.
The Uric Acid Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Uric Acid Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Uric Acid Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Uric Acid Drug Market Report

Report Metric Details
Report Name Uric Acid Drug Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca plc, Boehringer Ingelheim GmbH, Teijin Pharma Ltd, Regeneron Pharmaceuticals, GlaxoSmithKline plc, Merck & Co. Inc, Novartis AG, Savient Pharmaceuticals, Ironwood Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Uric Acid Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Uric Acid Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Uric Acid Drug Market report?

Ans: The main players in the Uric Acid Drug Market are AstraZeneca plc, Boehringer Ingelheim GmbH, Teijin Pharma Ltd, Regeneron Pharmaceuticals, GlaxoSmithKline plc, Merck & Co. Inc, Novartis AG, Savient Pharmaceuticals, Ironwood Pharmaceuticals

What are the Application segmentation covered in the Uric Acid Drug Market report?

Ans: The Applications covered in the Uric Acid Drug Market report are Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

What are the Type segmentation covered in the Uric Acid Drug Market report?

Ans: The Types covered in the Uric Acid Drug Market report are Allopurinol, Febuxostat, Probenecid

Recommended Reports

Metabolic Disease Drugs

Digestive Disorders Treatment

Renal & Urinary Drugs

1 Uric Acid Drug Market Overview
1.1 Product Definition
1.2 Uric Acid Drug by Type
1.2.1 Global Uric Acid Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Allopurinol
1.2.3 Febuxostat
1.2.4 Probenecid
1.3 Uric Acid Drug by Application
1.3.1 Global Uric Acid Drug Market Value by Application (2024 VS 2031)
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital Pharmacies
1.4 Global Uric Acid Drug Market Size Estimates and Forecasts
1.4.1 Global Uric Acid Drug Revenue 2020-2031
1.4.2 Global Uric Acid Drug Sales 2020-2031
1.4.3 Global Uric Acid Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Uric Acid Drug Market Competition by Manufacturers
2.1 Global Uric Acid Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global Uric Acid Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Uric Acid Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Uric Acid Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Uric Acid Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Uric Acid Drug, Product Type & Application
2.7 Global Key Manufacturers of Uric Acid Drug, Date of Enter into This Industry
2.8 Global Uric Acid Drug Market Competitive Situation and Trends
2.8.1 Global Uric Acid Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Uric Acid Drug Players Market Share by Revenue
2.8.3 Global Uric Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Uric Acid Drug Market Scenario by Region
3.1 Global Uric Acid Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Uric Acid Drug Sales by Region: 2020-2031
3.2.1 Global Uric Acid Drug Sales by Region: 2020-2025
3.2.2 Global Uric Acid Drug Sales by Region: 2026-2031
3.3 Global Uric Acid Drug Revenue by Region: 2020-2031
3.3.1 Global Uric Acid Drug Revenue by Region: 2020-2025
3.3.2 Global Uric Acid Drug Revenue by Region: 2026-2031
3.4 North America Uric Acid Drug Market Facts & Figures by Country
3.4.1 North America Uric Acid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Uric Acid Drug Sales by Country (2020-2031)
3.4.3 North America Uric Acid Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Uric Acid Drug Market Facts & Figures by Country
3.5.1 Europe Uric Acid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Uric Acid Drug Sales by Country (2020-2031)
3.5.3 Europe Uric Acid Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Uric Acid Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Uric Acid Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Uric Acid Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific Uric Acid Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Uric Acid Drug Market Facts & Figures by Country
3.7.1 Latin America Uric Acid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Uric Acid Drug Sales by Country (2020-2031)
3.7.3 Latin America Uric Acid Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Uric Acid Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Uric Acid Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Uric Acid Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa Uric Acid Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Uric Acid Drug Sales by Type (2020-2031)
4.1.1 Global Uric Acid Drug Sales by Type (2020-2025)
4.1.2 Global Uric Acid Drug Sales by Type (2026-2031)
4.1.3 Global Uric Acid Drug Sales Market Share by Type (2020-2031)
4.2 Global Uric Acid Drug Revenue by Type (2020-2031)
4.2.1 Global Uric Acid Drug Revenue by Type (2020-2025)
4.2.2 Global Uric Acid Drug Revenue by Type (2026-2031)
4.2.3 Global Uric Acid Drug Revenue Market Share by Type (2020-2031)
4.3 Global Uric Acid Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global Uric Acid Drug Sales by Application (2020-2031)
5.1.1 Global Uric Acid Drug Sales by Application (2020-2025)
5.1.2 Global Uric Acid Drug Sales by Application (2026-2031)
5.1.3 Global Uric Acid Drug Sales Market Share by Application (2020-2031)
5.2 Global Uric Acid Drug Revenue by Application (2020-2031)
5.2.1 Global Uric Acid Drug Revenue by Application (2020-2025)
5.2.2 Global Uric Acid Drug Revenue by Application (2026-2031)
5.2.3 Global Uric Acid Drug Revenue Market Share by Application (2020-2031)
5.3 Global Uric Acid Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca plc
6.1.1 AstraZeneca plc Company Information
6.1.2 AstraZeneca plc Description and Business Overview
6.1.3 AstraZeneca plc Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca plc Uric Acid Drug Product Portfolio
6.1.5 AstraZeneca plc Recent Developments/Updates
6.2 Boehringer Ingelheim GmbH
6.2.1 Boehringer Ingelheim GmbH Company Information
6.2.2 Boehringer Ingelheim GmbH Description and Business Overview
6.2.3 Boehringer Ingelheim GmbH Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Boehringer Ingelheim GmbH Uric Acid Drug Product Portfolio
6.2.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.3 Teijin Pharma Ltd
6.3.1 Teijin Pharma Ltd Company Information
6.3.2 Teijin Pharma Ltd Description and Business Overview
6.3.3 Teijin Pharma Ltd Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teijin Pharma Ltd Uric Acid Drug Product Portfolio
6.3.5 Teijin Pharma Ltd Recent Developments/Updates
6.4 Regeneron Pharmaceuticals
6.4.1 Regeneron Pharmaceuticals Company Information
6.4.2 Regeneron Pharmaceuticals Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Regeneron Pharmaceuticals Uric Acid Drug Product Portfolio
6.4.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.5 GlaxoSmithKline plc
6.5.1 GlaxoSmithKline plc Company Information
6.5.2 GlaxoSmithKline plc Description and Business Overview
6.5.3 GlaxoSmithKline plc Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline plc Uric Acid Drug Product Portfolio
6.5.5 GlaxoSmithKline plc Recent Developments/Updates
6.6 Merck & Co. Inc
6.6.1 Merck & Co. Inc Company Information
6.6.2 Merck & Co. Inc Description and Business Overview
6.6.3 Merck & Co. Inc Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck & Co. Inc Uric Acid Drug Product Portfolio
6.6.5 Merck & Co. Inc Recent Developments/Updates
6.7 Novartis AG
6.7.1 Novartis AG Company Information
6.7.2 Novartis AG Description and Business Overview
6.7.3 Novartis AG Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novartis AG Uric Acid Drug Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 Savient Pharmaceuticals
6.8.1 Savient Pharmaceuticals Company Information
6.8.2 Savient Pharmaceuticals Description and Business Overview
6.8.3 Savient Pharmaceuticals Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Savient Pharmaceuticals Uric Acid Drug Product Portfolio
6.8.5 Savient Pharmaceuticals Recent Developments/Updates
6.9 Ironwood Pharmaceuticals
6.9.1 Ironwood Pharmaceuticals Company Information
6.9.2 Ironwood Pharmaceuticals Description and Business Overview
6.9.3 Ironwood Pharmaceuticals Uric Acid Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ironwood Pharmaceuticals Uric Acid Drug Product Portfolio
6.9.5 Ironwood Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Uric Acid Drug Industry Chain Analysis
7.2 Uric Acid Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Uric Acid Drug Production Mode & Process Analysis
7.4 Uric Acid Drug Sales and Marketing
7.4.1 Uric Acid Drug Sales Channels
7.4.2 Uric Acid Drug Distributors
7.5 Uric Acid Drug Customer Analysis
8 Uric Acid Drug Market Dynamics
8.1 Uric Acid Drug Industry Trends
8.2 Uric Acid Drug Market Drivers
8.3 Uric Acid Drug Market Challenges
8.4 Uric Acid Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Boehringer Ingelheim GmbH
Teijin Pharma Ltd
Regeneron Pharmaceuticals
GlaxoSmithKline PLC
Merck& Co. Inc
Novartis
Savient Pharmaceuticals
Ironwood Pharmaceuticals
List of Tables
 Table 1. Global Uric Acid Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Uric Acid Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Uric Acid Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Uric Acid Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Uric Acid Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Uric Acid Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Uric Acid Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Uric Acid Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Uric Acid Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Uric Acid Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Uric Acid Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Uric Acid Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Uric Acid Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uric Acid Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Uric Acid Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Uric Acid Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global Uric Acid Drug Sales Market Share by Region (2020-2025)
 Table 19. Global Uric Acid Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global Uric Acid Drug Sales Market Share by Region (2026-2031)
 Table 21. Global Uric Acid Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Uric Acid Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global Uric Acid Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Uric Acid Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America Uric Acid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Uric Acid Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America Uric Acid Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America Uric Acid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Uric Acid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Uric Acid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Uric Acid Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Uric Acid Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Uric Acid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Uric Acid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Uric Acid Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Uric Acid Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Uric Acid Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Uric Acid Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Uric Acid Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Uric Acid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Uric Acid Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Uric Acid Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Uric Acid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Uric Acid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Uric Acid Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Uric Acid Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Uric Acid Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Uric Acid Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Uric Acid Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Uric Acid Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global Uric Acid Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global Uric Acid Drug Sales Market Share by Type (2020-2025)
 Table 53. Global Uric Acid Drug Sales Market Share by Type (2026-2031)
 Table 54. Global Uric Acid Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Uric Acid Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Uric Acid Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global Uric Acid Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global Uric Acid Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Uric Acid Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Uric Acid Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global Uric Acid Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global Uric Acid Drug Sales Market Share by Application (2020-2025)
 Table 63. Global Uric Acid Drug Sales Market Share by Application (2026-2031)
 Table 64. Global Uric Acid Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Uric Acid Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Uric Acid Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global Uric Acid Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global Uric Acid Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Uric Acid Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca plc Company Information
 Table 71. AstraZeneca plc Description and Business Overview
 Table 72. AstraZeneca plc Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca plc Uric Acid Drug Product
 Table 74. AstraZeneca plc Recent Developments/Updates
 Table 75. Boehringer Ingelheim GmbH Company Information
 Table 76. Boehringer Ingelheim GmbH Description and Business Overview
 Table 77. Boehringer Ingelheim GmbH Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Boehringer Ingelheim GmbH Uric Acid Drug Product
 Table 79. Boehringer Ingelheim GmbH Recent Developments/Updates
 Table 80. Teijin Pharma Ltd Company Information
 Table 81. Teijin Pharma Ltd Description and Business Overview
 Table 82. Teijin Pharma Ltd Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Teijin Pharma Ltd Uric Acid Drug Product
 Table 84. Teijin Pharma Ltd Recent Developments/Updates
 Table 85. Regeneron Pharmaceuticals Company Information
 Table 86. Regeneron Pharmaceuticals Description and Business Overview
 Table 87. Regeneron Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Regeneron Pharmaceuticals Uric Acid Drug Product
 Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 90. GlaxoSmithKline plc Company Information
 Table 91. GlaxoSmithKline plc Description and Business Overview
 Table 92. GlaxoSmithKline plc Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline plc Uric Acid Drug Product
 Table 94. GlaxoSmithKline plc Recent Developments/Updates
 Table 95. Merck & Co. Inc Company Information
 Table 96. Merck & Co. Inc Description and Business Overview
 Table 97. Merck & Co. Inc Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Merck & Co. Inc Uric Acid Drug Product
 Table 99. Merck & Co. Inc Recent Developments/Updates
 Table 100. Novartis AG Company Information
 Table 101. Novartis AG Description and Business Overview
 Table 102. Novartis AG Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Novartis AG Uric Acid Drug Product
 Table 104. Novartis AG Recent Developments/Updates
 Table 105. Savient Pharmaceuticals Company Information
 Table 106. Savient Pharmaceuticals Description and Business Overview
 Table 107. Savient Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Savient Pharmaceuticals Uric Acid Drug Product
 Table 109. Savient Pharmaceuticals Recent Developments/Updates
 Table 110. Ironwood Pharmaceuticals Company Information
 Table 111. Ironwood Pharmaceuticals Description and Business Overview
 Table 112. Ironwood Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Ironwood Pharmaceuticals Uric Acid Drug Product
 Table 114. Ironwood Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Uric Acid Drug Distributors List
 Table 118. Uric Acid Drug Customers List
 Table 119. Uric Acid Drug Market Trends
 Table 120. Uric Acid Drug Market Drivers
 Table 121. Uric Acid Drug Market Challenges
 Table 122. Uric Acid Drug Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Uric Acid Drug
 Figure 2. Global Uric Acid Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Uric Acid Drug Market Share by Type: 2024 & 2031
 Figure 4. Allopurinol Product Picture
 Figure 5. Febuxostat Product Picture
 Figure 6. Probenecid Product Picture
 Figure 7. Global Uric Acid Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Uric Acid Drug Market Share by Application: 2024 & 2031
 Figure 9. Online Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Hospital Pharmacies
 Figure 12. Global Uric Acid Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Uric Acid Drug Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Uric Acid Drug Sales (2020-2031) & (K Units)
 Figure 15. Global Uric Acid Drug Average Price (US$/Unit) & (2020-2031)
 Figure 16. Uric Acid Drug Report Years Considered
 Figure 17. Uric Acid Drug Sales Share by Manufacturers in 2024
 Figure 18. Global Uric Acid Drug Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Uric Acid Drug Players: Market Share by Revenue in Uric Acid Drug in 2024
 Figure 20. Uric Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Uric Acid Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Uric Acid Drug Sales Market Share by Country (2020-2031)
 Figure 23. North America Uric Acid Drug Revenue Market Share by Country (2020-2031)
 Figure 24. United States Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Uric Acid Drug Sales Market Share by Country (2020-2031)
 Figure 27. Europe Uric Acid Drug Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Uric Acid Drug Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Uric Acid Drug Revenue Market Share by Region (2020-2031)
 Figure 35. China Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Uric Acid Drug Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Uric Acid Drug Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Uric Acid Drug Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Uric Acid Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Uric Acid Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Uric Acid Drug by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Uric Acid Drug by Type (2020-2031)
 Figure 56. Global Uric Acid Drug Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Uric Acid Drug by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Uric Acid Drug by Application (2020-2031)
 Figure 59. Global Uric Acid Drug Price (US$/Unit) by Application (2020-2031)
 Figure 60. Uric Acid Drug Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Uric Acid Market Research Report 2024
Antihyperuricemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gout Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Uric Acid Test Service Market Research Report 2024
Allopurinol Intermediate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gout Drugs Market Research Report 2024
Orotic Aciduria Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Uric Acid Detector Market Research Report 2024
Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Uric Acid Health Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antigout Drug Market Research Report 2024
Renal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Purine Market Research Report 2024
Global Urinary Products Market Research Report 2025
Erythorbic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hydroxyurea Market Research Report 2025
Cholesterol Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatoid Arthritis RA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Urological Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions